Home/Filings/4/0001144204-15-056995
4//SEC Filing

Tonix Pharmaceuticals Holding Corp. 4

Accession 0001144204-15-056995

$TNXPCIK 0001430306operating

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 11:47 AM ET

Size

5.2 KB

Accession

0001144204-15-056995

Insider Transaction Report

Form 4
Period: 2015-09-28
GERSHELL LELAND
CFO and Treasurer
Transactions
  • Purchase

    Common Stock, $0.001 par value

    2015-09-28$5.83/sh+400$2,33019,260 total
Footnotes (1)
  • [F1]The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $5.825. The range of purchase prices on the transaction date was $5.82 to $5.83 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001430306

Filing Metadata

Form type
4
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 11:47 AM ET
Size
5.2 KB